{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:04:25Z","timestamp":1779084265653,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"THENEWWAY SRL"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s13555-022-00684-3","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T12:17:58Z","timestamp":1643717878000},"page":"671-681","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Dimethyl Fumarate's Effectiveness and Safety in Psoriasis: A Real-Life Experience During the COVID-19 Pandemic"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4773-6993","authenticated-orcid":false,"given":"Maria","family":"Esposito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Campanati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Giunta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Calianno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Diotallevi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Offidani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Concetta","family":"Fargnoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,1]]},"reference":[{"issue":"1","key":"684_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/jdv.15922","volume":"34","author":"PCM van de Kerkhof","year":"2020","unstructured":"van de Kerkhof PCM, Loewe R, Mrowietz U, Falques M, Pau-Charles I, Szepietowski JC. Quality of life outcomes in adults with moderate-to-severe plaque psoriasis treated with dimethylfumarate (DMF): a post hoc analysis of the BRIDGE study. J Eur Acad Dermatol Venereol. 2020;34(1):119\u201326.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"684_CR2","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s13555-020-00409-4","volume":"10","author":"DMW Balak","year":"2020","unstructured":"Balak DMW, Gerdes S, Parodi A, Salgado-Boquete L. Long-term safety of oral systemic therapies for psoriasis: a comprehensive review of the literature. Dermatol Ther (Heidelb). 2020;10(4):589\u2013613.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"Suppl 3","key":"684_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/jdv.15218","volume":"32","author":"U Mrowietz","year":"2018","unstructured":"Mrowietz U, Barker J, Boehncke WH, et al. Clinical use of dimethyl fumarate in moderate-to-severe plaque-type psoriasis: a European expert consensus. J Eur Acad Dermatol Venereol. 2018;32(Suppl 3):3\u201314.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"684_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/14728214.2020.1745773","volume":"25","author":"EA Balogh","year":"2020","unstructured":"Balogh EA, Bashyam AM, Ghamrawi RI, Feldman SR. Emerging systemic drugs in the treatment of plaque psoriasis. Expert Opin Emerg Drugs. 2020;25(2):89\u2013100.","journal-title":"Expert Opin Emerg Drugs"},{"issue":"1","key":"684_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s40265-017-0854-6","volume":"78","author":"HA Blair","year":"2018","unstructured":"Blair HA. Dimethyl fumarate: a review in moderate to severe plaque psoriasis. Drugs. 2018;78(1):123\u201330.","journal-title":"Drugs"},{"issue":"1","key":"684_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/ph14010015","volume":"14","author":"CA Timpani","year":"2020","unstructured":"Timpani CA, Rybalka E. Calming the (cytokine) storm: dimethyl fumarate as a therapeutic candidate for COVID-19. Pharmaceuticals (Basel). 2020;14(1):15.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"4","key":"684_CR7","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3390\/vaccines8040769","volume":"8","author":"A Chiricozzi","year":"2020","unstructured":"Chiricozzi A, Gisondi P, Bellinato F, Girolomoni G. Immune response to vaccination in patients with psoriasis treated with systemic therapies. Vaccines (Basel). 2020;8(4):769.","journal-title":"Vaccines (Basel)"},{"issue":"10","key":"684_CR8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3390\/ph13100306","volume":"13","author":"S Kourakis","year":"2020","unstructured":"Kourakis S, Timpani CA, de Haan JB, Gueven N, Fischer D, Rybalka E. Dimethyl fumarate and its esters: a drug with broad clinical utility? Pharmaceuticals (Basel). 2020;13(10):306.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"684_CR9","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/bjd.19229","volume":"184","author":"J Sulaimani","year":"2021","unstructured":"Sulaimani J, Cluxton D, Clowry J, et al. Dimethyl fumarate modulates the Treg-Th17 cell axis in psoriasis patients. Br J Dermatol. 2021;184(3):495\u2013503.","journal-title":"Br J Dermatol"},{"issue":"1","key":"684_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3109\/09546634.2015.1050980","volume":"27","author":"R Lijnen","year":"2016","unstructured":"Lijnen R, Otters E, Balak D, Thio B. Long-term safety and effectiveness of high-dose dimethylfumarate in the treatment of moderate to severe psoriasis: a prospective single-blinded follow-up study. J Dermatol Treat. 2016;27(1):31\u20136.","journal-title":"J Dermatol Treat"},{"issue":"3","key":"684_CR11","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/bjd.14947","volume":"176","author":"U Mrowietz","year":"2017","unstructured":"Mrowietz U, Szepietowski JC, Loewe R, et al. Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm\u00ae- and placebo-controlled trial (BRIDGE). Br J Dermatol. 2017;176(3):615\u201323.","journal-title":"Br J Dermatol"},{"issue":"10","key":"684_CR12","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1111\/jdv.15019","volume":"32","author":"H Dickel","year":"2018","unstructured":"Dickel H, Bruckner T, Altmeyer P. Long-term real-life safety profile and effectiveness of fumaric acid esters in psoriasis patients: a single-centre, retrospective, observational study. J Eur Acad Dermatol Venereol. 2018;32(10):1710\u201327.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"684_CR13","first-page":"603","volume":"7","author":"K Reich","year":"2009","unstructured":"Reich K, Thaci D, Mrowietz U, Kamps A, Neureither M, Luger T. Efficacy and safety of fumaric acid esters in the long-term treatment of psoriasis\u2014a retrospective study (FUTURE). J Dtsch Dermatol Ges. 2009;7(7):603\u201311.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"19\u201320","key":"684_CR14","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00508-019-01551-6","volume":"131","author":"P Sator","year":"2019","unstructured":"Sator P, Loewe R, Zamani O, et al. Dimethyl fumarate is efficacious in severe plaque psoriasis: post hoc analysis from the BRIDGE trial in Austria. Wien Klin Wochenschr. 2019;131(19\u201320):485\u201392.","journal-title":"Wien Klin Wochenschr"},{"issue":"2","key":"684_CR15","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/jdv.16926","volume":"35","author":"A Nast","year":"2021","unstructured":"Nast A, Smith C, Spuls PI, et al. EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris\u2014part 2: specific clinical and comorbid situations. J Eur Acad Dermatol Venereol. 2021;35(2):281\u2013317.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"684_CR16","unstructured":"Skilarence, Summary of Product Characteristic. Last edition June 2021. https:\/\/www.ema.europa.eu"},{"key":"684_CR17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000250839","volume":"157","author":"T Fredriksson","year":"1978","unstructured":"Fredriksson T, Pettersson U. Severe psoriasis\u2014oral therapy with a new retinoid. Dermatologica. 1978;157:238\u201344.","journal-title":"Dermatologica"},{"key":"684_CR18","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1111\/jdv.13354","volume":"29","author":"A Nast","year":"2015","unstructured":"Nast A, Gisondi P, Ormerod AD, et al. European S3-Guidelines on the systemic treatment of psoriasis vulgaris\u2013update 2015\u2013short version\u2013EDF in cooperation with EADV and IPC. J Eur Acad Dermatol Venereol. 2015;29:2277\u201394.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"684_CR19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)\u2014a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210\u20136.","journal-title":"Clin Exp Dermatol"},{"key":"684_CR20","first-page":"1","volume":"2021","author":"U Mrowietz","year":"2020","unstructured":"Mrowietz U, Van de Kerkhof P, Schoenenberger A, et al. Efficacy of dimethyl fumarate treatment for moderate-to-severe plaque psoriasis: presentation extracts from the 29th EADV virtual congress, 29\u201331 October. Expert Rev Clin Immunol. 2020;2021:1\u201311.","journal-title":"Expert Rev Clin Immunol"},{"issue":"9","key":"684_CR21","first-page":"906","volume":"17","author":"S Falkvoll","year":"2019","unstructured":"Falkvoll S, Gerdes S, Mrowietz U. Switch of psoriasis therapy from a fumaric acid ester mixture to dimethyl fumarate monotherapy: results of a prospective study. J Dtsch Dermatol Ges. 2019;17(9):906\u201312.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"4","key":"684_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/14740338.2020.1736553","volume":"19","author":"R Reszke","year":"2020","unstructured":"Reszke R, Szepietowski JC. A safety evaluation of dimethyl fumarate in moderate-to-severe psoriasis. Expert Opin Drug Saf. 2020;19(4):373\u201380.","journal-title":"Expert Opin Drug Saf"},{"issue":"5","key":"684_CR23","doi-asserted-by":"publisher","first-page":"e15066","DOI":"10.1111\/dth.15066","volume":"34","author":"M Corazza","year":"2021","unstructured":"Corazza M, Odorici G, Conti A, et al. Dimethyl fumarate treatment for psoriasis in a real-life setting: a multicentric retrospective study. Dermatol Ther. 2021;34(5):e15066.","journal-title":"Dermatol Ther."},{"key":"684_CR24","doi-asserted-by":"crossref","unstructured":"Filippi F, Sacchelli L, DI Altobrando A, Pileri A, Bardazzi F. Dimethyl fumarate: a case of improvement of alcoholic steatohepatitis in an elderly psoriatic patient. Ital J Dermatol Venerol. 2021.","DOI":"10.23736\/S2784-8671.21.07051-1"},{"issue":"1","key":"684_CR25","doi-asserted-by":"publisher","first-page":"4938","DOI":"10.1038\/s41467-020-18764-3","volume":"11","author":"D Olagnier","year":"2020","unstructured":"Olagnier D, Farahani E, Thyrsted J, et al. SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate. Nat Commun. 2020;11(1):4938.","journal-title":"Nat Commun"},{"issue":"8","key":"684_CR26","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1111\/jdv.16646","volume":"34","author":"A Campanati","year":"2020","unstructured":"Campanati A, Brisigotti V, Diotallevi F, et al. Active implications for dermatologists in \u2018SARS-CoV-2 ERA\u2019: personal experience and review of literature. J Eur Acad Dermatol Venereol. 2020;34(8):1626\u201332.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"684_CR27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1080\/14712598.2021.1853698","volume":"21","author":"M Talamonti","year":"2021","unstructured":"Talamonti M, Galluzzo M, Chiricozzi A, et al. Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: risk analysis from the PSO-BIO-COVID observational study. Expert Opin Biol Ther. 2021;21(2):271\u20137.","journal-title":"Expert Opin Biol Ther"},{"key":"684_CR28","doi-asserted-by":"publisher","first-page":"102925","DOI":"10.1016\/j.msard.2021.102925","volume":"51","author":"M Al Jumah","year":"2021","unstructured":"Al Jumah M, Abulaban A, Aggad H, et al. Managing multiple sclerosis in the Covid19 era: a review of the literature and consensus report from a panel of experts in Saudi Arabia. Mult Scler Relat Disord. 2021;51:102925.","journal-title":"Mult Scler Relat Disord"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00684-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-022-00684-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00684-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T10:59:48Z","timestamp":1647946788000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-022-00684-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["684"],"URL":"https:\/\/doi.org\/10.1007\/s13555-022-00684-3","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,1]]},"assertion":[{"value":"21 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}